Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Return on Invested Capital (2021 - 2025)

Tango Therapeutics (TNGX) has 4 years of Return on Invested Capital data on record, last reported at 0.68% in Q4 2024.

  • For Q4 2024, Return on Invested Capital fell 25.0% year-over-year to 0.68%; the TTM value through Dec 2024 reached 0.68%, down 25.0%, while the annual FY2025 figure was 0.41%, 24.0% up from the prior year.
  • Return on Invested Capital reached 0.68% in Q4 2024 per TNGX's latest filing, down from 0.59% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.15% in Q4 2021 and bottomed at 0.71% in Q2 2021.
  • Average Return on Invested Capital over 4 years is 0.43%, with a median of 0.45% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 41bps in 2022, then fell -28bps in 2023.
  • A 4-year view of Return on Invested Capital shows it stood at 0.15% in 2021, then plummeted by -176bps to 0.43% in 2022, then decreased by -1bps to 0.43% in 2023, then tumbled by -58bps to 0.68% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.68% in Q4 2024, 0.59% in Q3 2024, and 0.52% in Q2 2024.